Showing 15 posts of 736 posts found.


Sanofi and GSK set aside rivalry with “unprecedented” COVID-19 vaccine partnership

April 15, 2020
Research and Development COVID-19, GSK, Sanofi, coronavirus

Usual rivals Sanofi and GlaxoSmithKline have said they are to put aside competition with the forging of a new “unprecedented …


Clover Biopharmaceuticals partners up with GSK to accelerate coronavirus vaccine development

February 24, 2020
Sales and Marketing China, Clover Biopharmaceuticals, GSK, coronavirus, pharma

Chinese biotech firm Clover Biopharmaceuticals has joined the race to develop interventions against the ongoing coronavirus outbreak with the announcement …


GSK to axe 720 positions at Belgian vaccine facility

February 7, 2020
Manufacturing and Production, Medical Communications GSK, job cuts, pharma

GlaxoSmithKline has announced a cull of staff at its vaccine production site in Belgium, with 720 employees facing the axe. …


FDA fast-tracks GSK’s multiple myeloma drug after priority review

January 22, 2020
Research and Development BCMA, FDA, GSK, Phase 2 Trials, Phase Trials, multiple myeloma, myeloma

The FDA has fast tracked GlaxoSmithKline (GSK) antibody drug conjugate (ADC) belantamab mafodotin, for the treatment of patients with refractory …

GSK’s Nucala meets Phase 3 goal in reducing hypereosinophilic syndrome flare-ups

November 13, 2019
Research and Development GSK, Nucala, pharma

GlaxoSmithKline has unveiled new Phase 3 data for its IL-5 inhibitor Nucala (mepolizumab), revealing that the therapy met its primary …

Expanded EU label for Benlyta now covers paediatric lupus patients

October 30, 2019
Research and Development, Sales and Marketing Benlyta, Europe, GSK, Lupus, pharma

GlaxoSmithKline is celebrating the news that the European Commission has chosen to approve an expansion to the label of its …


GSK’s tuberculosis vaccine shows efficacy over three years in HIV negative patients

October 29, 2019
Manufacturing and Production, Research and Development GSK, IAVI, Vaccine, pharma, tuberculosis

Promising results have been revealed from a GlaxoSmithKline study, conducted in partnership with non-profit scientific research organisation IAVI, investigating the …


GSK Chief Emma Walmsley voices support for equal pay campaign

October 3, 2019
Medical Communications Emma Walmsley, GSK, GlaxoSmithKline, pharma

GlaxoSmithKline Chief Emma Walmsley has joined the chorus of more than a hundred of the UK’s most successful female business …


GSK’s Zejula slows disease progression in a range of ovarian cancers

October 2, 2019
Research and Development Cancer, ESMO 2019, GSK, Zejula, ovarian cancer, pharma

At the 2019 European Society for Medical Oncology (ESMO) congress, GlaxoSmithKline unveiled new Phase 3 data on Zejula (niraparib) for …

GlaxoSmithKline acquires Sitari Pharmaceuticals after progress in coeliac disease

September 11, 2019
Research and Development, Sales and Marketing Avalon Ventures, GSK, coeliac disease

Avalon Ventures has announced that it has entered into a definitive agreement with GSK for the acquisition of Sitari Pharmaceuticals …

Four perspectives from life sciences companies on multichannel engagement

August 23, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Biogen, GSK, Lifesciences, Teva, healthcare, pharma

By 2020, 70% of HCPs are expected to be digital natives, whose experiences with mobile, social, and digital technologies in …


GSK’s two drug HIV regimen effective when administered every two months

August 22, 2019
Research and Development AIDS, GSK, HIV, ViiV Healthcare, viral supression

GSK’s long-acting, two-drug HIV regimen was as effective in supressing patient’s viral loads when administered every two months (eight weeks), …


European approval for two new delivery formulations of GSK’s Nucala in severe eosinophilic asthma

August 2, 2019
Medical Communications, Sales and Marketing Europe, GSK, Nucala, asthma, pharma

Following closely on the heels of the news that its deal to merge Pfizer’s consumer health business with its own, …


GSK closes the deal with Pfizer over $9.8 billion consumer healthcare merger

August 1, 2019
Sales and Marketing GSK, Pfizer, merger, pharma

The $9.8 billion joint venture between major pharma firms GlaxoSmithKline and Pfizer to merge their consumer health operations has come …

GSK teams up with Strathclyde and University of Nottingham

July 16, 2019
Manufacturing and Production GSK, GlaxoSmithKline, UK, britain, pharma, universities

GlaxoSmithKline has teamed up with the University of Nottingham and the University of Strathclyde for a five-year partnership aimed at …

Latest content